Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia

A closer look at the role of siderosis

Joseph E. Maakaron, Maria Domenica Cappellini, Giovanna Graziadei, Jad Bou Ayache, Ali T. Taher

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Patients with thalassemia are often exposed to several risk factors for developing hepatocellular carcinoma (HCC) due to their repeated transfusions. However, even transfusion-independent patients with thalassemia intermedia (TI) can develop HCC, which is mainly attributed to a state of iron overload. We report here two cases and review the literature for the association between TI and HCC. Along with our cases, a total of 36 cases of HCC in thalassemic patients were reported in the literature. Of these, 22 (61%) were TI patients with 6 (27%) of them being hepatitis B and C negative. There was no consistency in their characteristics; therefore, we recommended screening thresholds for HCC in TI patients based on their total liver iron concentration (LIC).

Original languageEnglish
Pages (from-to)142-146
Number of pages5
JournalAnnals of Hepatology
Volume12
Issue number1
Publication statusPublished - Jan 2013

Fingerprint

Siderosis
beta-Thalassemia
Hepatitis
Hepatocellular Carcinoma
Iron Overload
Thalassemia
Hepatitis C
Hepatitis B
Iron
Liver

Keywords

  • Hepatocellular carcinoma
  • Iron overload
  • Liver iron concentration
  • Risk factor
  • Thalassemia intermedia

ASJC Scopus subject areas

  • Hepatology

Cite this

Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia : A closer look at the role of siderosis. / Maakaron, Joseph E.; Cappellini, Maria Domenica; Graziadei, Giovanna; Ayache, Jad Bou; Taher, Ali T.

In: Annals of Hepatology, Vol. 12, No. 1, 01.2013, p. 142-146.

Research output: Contribution to journalArticle

@article{4deec30359fc4ae28ad9fb818838efff,
title = "Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia: A closer look at the role of siderosis",
abstract = "Patients with thalassemia are often exposed to several risk factors for developing hepatocellular carcinoma (HCC) due to their repeated transfusions. However, even transfusion-independent patients with thalassemia intermedia (TI) can develop HCC, which is mainly attributed to a state of iron overload. We report here two cases and review the literature for the association between TI and HCC. Along with our cases, a total of 36 cases of HCC in thalassemic patients were reported in the literature. Of these, 22 (61{\%}) were TI patients with 6 (27{\%}) of them being hepatitis B and C negative. There was no consistency in their characteristics; therefore, we recommended screening thresholds for HCC in TI patients based on their total liver iron concentration (LIC).",
keywords = "Hepatocellular carcinoma, Iron overload, Liver iron concentration, Risk factor, Thalassemia intermedia",
author = "Maakaron, {Joseph E.} and Cappellini, {Maria Domenica} and Giovanna Graziadei and Ayache, {Jad Bou} and Taher, {Ali T.}",
year = "2013",
month = "1",
language = "English",
volume = "12",
pages = "142--146",
journal = "Annals of Hepatology",
issn = "1665-2681",
publisher = "Mexican Association of Hepatology",
number = "1",

}

TY - JOUR

T1 - Hepatocellular carcinoma in hepatitis-negative patients with thalassemia intermedia

T2 - A closer look at the role of siderosis

AU - Maakaron, Joseph E.

AU - Cappellini, Maria Domenica

AU - Graziadei, Giovanna

AU - Ayache, Jad Bou

AU - Taher, Ali T.

PY - 2013/1

Y1 - 2013/1

N2 - Patients with thalassemia are often exposed to several risk factors for developing hepatocellular carcinoma (HCC) due to their repeated transfusions. However, even transfusion-independent patients with thalassemia intermedia (TI) can develop HCC, which is mainly attributed to a state of iron overload. We report here two cases and review the literature for the association between TI and HCC. Along with our cases, a total of 36 cases of HCC in thalassemic patients were reported in the literature. Of these, 22 (61%) were TI patients with 6 (27%) of them being hepatitis B and C negative. There was no consistency in their characteristics; therefore, we recommended screening thresholds for HCC in TI patients based on their total liver iron concentration (LIC).

AB - Patients with thalassemia are often exposed to several risk factors for developing hepatocellular carcinoma (HCC) due to their repeated transfusions. However, even transfusion-independent patients with thalassemia intermedia (TI) can develop HCC, which is mainly attributed to a state of iron overload. We report here two cases and review the literature for the association between TI and HCC. Along with our cases, a total of 36 cases of HCC in thalassemic patients were reported in the literature. Of these, 22 (61%) were TI patients with 6 (27%) of them being hepatitis B and C negative. There was no consistency in their characteristics; therefore, we recommended screening thresholds for HCC in TI patients based on their total liver iron concentration (LIC).

KW - Hepatocellular carcinoma

KW - Iron overload

KW - Liver iron concentration

KW - Risk factor

KW - Thalassemia intermedia

UR - http://www.scopus.com/inward/record.url?scp=84876284207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876284207&partnerID=8YFLogxK

M3 - Article

VL - 12

SP - 142

EP - 146

JO - Annals of Hepatology

JF - Annals of Hepatology

SN - 1665-2681

IS - 1

ER -